Peter Hutt

Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD.

Develops drugs to treat mitochondrial diseases

Engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system

Operates as a biopharmaceutical company that develops novel medicines

Develops biopharmaceutical preparations

Develops silicon-based medical nanotechnology devices

Provides medical diagnostic services

Produces brain imaging software by utilizing high resolution gamma cameras

Develops capillary whole blood sampling technology

Develops targeted immunotherapies and vaccines to treat and prevent diseases

Provides biopharmaceutical services

Functions as a College/University

Develops and sells beauty products

Develops e-process software solutions for accelerating global pharmaceutical development

Provides legal services

Discovers and develops therapeutics for cancer, autoimmune and inflammatory diseases

Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases

Functions as a College/University

Provides community based preventive health screenings services

Engages in the improvement of health and saving lives

Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy

Functions as a College/University

Develops cardiovascular therapeutics

Operates agencies to protect health and human services

Operates as a professional membership organization

Provides biomedical community services

The Society for Risk Analysis is an international, multidisciplinary scholarly organization dedicated to advancing the science and practice of risk analysis. The non-profit company is based in McLean, VA. It encompasses activities including risk assessment, characterization, communication, management, governance, and policy across individual, organizational, and societal levels. The organization integrates disciplines such as statistics, psychology, social sciences, engineering, and medicine to address complex risk issues related to health, environment, security, and technology. It supports a community of members from academia, government, industry, consulting, and NGOs, and fosters collaboration through specialty groups focused on domains like ecological risk assessment, occupational health and safety, risk communication, applied risk management, and justice and equity. The society organizes workshops, webinars, and discussions on topics such as climate change impacts, workplace hazards, and risk perception, and provides resources including scientific journals, webinars, podcasts, teaching materials, and career development opportunities. It hosts annual meetings and world congresses for researchers, practitioners, and policymakers, and promotes ethical standards, transparency, and responsibility in risk analysis. The company was founded by Elizabeth L. Anderson.

Provides medical drug and product development review process

Kearny Venture Partners invests in companies located in the United States. The firm focuses on healthcare and healthcare product sector. It participates in early stage transactions.

InCube Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, healthcare and medical devices. It provides financing for early, mid and late stage capital requirements.

Provides electronic document management and online personal health record and storage solutions

Institute For Health Policy Analysis, Inc. is a private company based in Washington, DC.

Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions.

Develops messenger RNA therapeutics

Develops, manufactures and commercializes novel, differentiated aesthetic products

Provides animal research and testing services

Functions as a College/University

Discovers and develops cancer therapeutics and drugs

Develops novel treatments for diseases related to the human microbiome

Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology

Functions as a College/University

Functions as a College/University

Provides health screening services

Develops red cell therapeutics for cancer treatment

Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome

Manufactures and sells gut microbiome products through online

Develops immunobiotic therapeutics

Manufactures applications of low-dose carbon monoxide

Develops novel platinum therapies

Acts as a trade association which represents the life sciences industry of California

Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics

Develops formulations and medicines

Operates as biotechnology company

Develops pharmaceutical products

Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity